NAYA Biosciences Inc. (NAYA)
NAYA Biosciences Statistics
Share Statistics
NAYA Biosciences has 7.09M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 7.09M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 5 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 0, so 0% of the outstanding shares have been sold short.
| Short Interest | 0 |
| Short % of Shares Out | 0% |
| Short % of Float | 0% |
| Short Ratio (days to cover) | 0 |
Valuation Ratios
The PE ratio is -0.27 and the forward PE ratio is null. NAYA Biosciences's PEG ratio is 0.01.
| PE Ratio | -0.27 |
| Forward PE | n/a |
| PS Ratio | 0.72 |
| Forward PS | 0.3 |
| PB Ratio | 2.43 |
| P/FCF Ratio | -0.42 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for NAYA Biosciences Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16, with a Debt / Equity ratio of 7.06.
| Current Ratio | 0.16 |
| Quick Ratio | 0.12 |
| Debt / Equity | 7.06 |
| Total Debt / Capitalization | 87.59 |
| Cash Flow / Debt | -0.75 |
| Interest Coverage | -7.31 |
Financial Efficiency
Return on equity (ROE) is -9% and return on capital (ROIC) is -94.39%.
| Return on Equity (ROE) | -9% |
| Return on Assets (ROA) | -0.43% |
| Return on Capital (ROIC) | -94.39% |
| Revenue Per Employee | $100,685.83 |
| Profits Per Employee | $-267,820.4 |
| Employee Count | 30 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 7.31 |
Taxes
| Income Tax | 27.79K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 1.62, so NAYA Biosciences's price volatility has been higher than the market average.
| Beta | 1.62 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.56 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 34.47 |
| Average Volume (20 Days) | 170.93K |
Income Statement
In the last 12 months, NAYA Biosciences had revenue of 3.02M and earned -8.03M in profits. Earnings per share was -5.13.
| Revenue | 3.02M |
| Gross Profit | 1.09M |
| Operating Income | -6.77M |
| Net Income | -8.03M |
| EBITDA | -6.88M |
| EBIT | -6.77M |
| Earnings Per Share (EPS) | -5.13 |
Balance Sheet
The company has 232.42K in cash and 6.3M in debt, giving a net cash position of -6.07M.
| Cash & Cash Equivalents | 232.42K |
| Total Debt | 6.3M |
| Net Cash | -6.07M |
| Retained Earnings | -57.82M |
| Total Assets | 17.02M |
| Working Capital | -6.7M |
Cash Flow
In the last 12 months, operating cash flow was -4.76M and capital expenditures -444.72K, giving a free cash flow of -5.2M.
| Operating Cash Flow | -4.76M |
| Capital Expenditures | -444.72K |
| Free Cash Flow | -5.2M |
| FCF Per Share | -1.66 |
Margins
Gross margin is 35.96%, with operating and profit margins of -224.04% and -266%.
| Gross Margin | 35.96% |
| Operating Margin | -224.04% |
| Pretax Margin | -265.08% |
| Profit Margin | -266% |
| EBITDA Margin | -227.77% |
| EBIT Margin | -224.04% |
| FCF Margin | -172.15% |
Dividends & Yields
NAYA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1465.71% |
| FCF Yield | -210.33% |
Analyst Forecast
The average price target for NAYA is $2, which is 471.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $2 |
| Price Target Difference | 471.4% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jul 28, 2023. It was a backward split with a ratio of 1:20.
| Last Split Date | Jul 28, 2023 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -6.48 |
| Piotroski F-Score | 2 |